Loading the section…

ZEPP: financial statements from SEC — TradeAlmanac

ZEPP

Zepp Health Corporation: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	31/12/2025	31/12/2024	31/12/2023	31/12/2022
Revenue	259M	183M	353M	614M
Cost of revenue	160M	112M	261M	495M
Gross profit	99M	70M	92M	119M
Research and development	45M	46M	52M	77M
Selling, general and administrative	29M	25M	27M	35M
Operating expenses	128M	117M	123M	181M
Operating income	−29M	−47M	−30M	−62M
Pre-tax income	−35M	−58M	−35M	−56M
Income tax	3M	14M	−2M	−10M
Net income	−40M	−76M	−31M	−43M
Earnings per share	−0.16	−0.29	−0.13	−0.18
Earnings per share, diluted	−0.16	−0.29	−0.13	−0.18
Weighted average shares	254M	259M	243M	246M
Weighted average shares, diluted	254M	259M	243M	246M

Balance sheet

Metric	19/08/2026	18/08/2026	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021
Cash and equivalents	—	—	57M	91M	134M	129M	237M
Short-term investments	—	—

Cash flow

Metric	31/12/2025	31/12/2024	31/12/2023	31/12/2022
Operating cash flow	−26M	−24M	43M	−117M
Depreciation and amortisation	5M	5M	8M	9M
Share-based compensation	2M	5M	9M	7M
Capital expenditure

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator